Novo Nordisk CDR (CAD Hedged) (NOVO : TSX)
Common Stock
$17.72
CAD
-0.62 (-3.38%)
Last updated: 2026-09-18
Get NOVO alerts:
NOVO
Novo Nordisk CDR (CAD Hedged)
WealthAwesomePerformance
1 Day
-1.61%
1 Week
-5.19%
1 Month
-6.44%
YTD
-18.94%
Key Statistics
Market Cap
$807.70B
52W High
$26.57
52W Low
$14.33
P/E Ratio
3.14
50 Day MA
$20.06
200 Day MA
$19.47
Beta
-
Dividend Yield
64.96%
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/18/2026 | $18.32 | $18.52 | $18.32 | $18.49 | $18.49 | 745 |
| 9/17/2026 | $17.97 | $18.41 | $17.97 | $18.34 | $18.34 | 5,108 |
| 9/16/2026 | $18.03 | $18.03 | $17.63 | $17.72 | $17.72 | 4,861 |
| 9/15/2026 | $18.12 | $18.13 | $17.95 | $18.01 | $18.01 | 6,954 |
| 9/14/2026 | $18.40 | $18.48 | $18.29 | $18.43 | $18.43 | 7,260 |
| 9/11/2026 | $18.18 | $18.25 | $17.97 | $18.21 | $18.21 | 6,818 |
| 9/10/2026 | $18.87 | $18.87 | $18.51 | $18.51 | $18.51 | 5,394 |
| 9/9/2026 | $18.91 | $18.94 | $18.67 | $18.69 | $18.69 | 4,874 |
| 9/8/2026 | $19.09 | $19.13 | $19.00 | $19.01 | $19.01 | 3,792 |
| 9/4/2026 | $19.52 | $19.66 | $19.39 | $19.66 | $19.66 | 3,900 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on NOVO's historical volatility
30-Day Vol
31.8%
Annualized
90-Day Vol
38.5%
Annualized
Trend (90d)
-39.8%
Annualized drift
90d Mean
C$16.04
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$17.63 | C$15.80 – C$19.68 |
| 60 trading days | C$16.82 | C$14.40 – C$19.64 |
| 90 trading days | C$16.04 | C$13.26 – C$19.40 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Novo Nordisk CDR (CAD Hedged)
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Financials
- Revenue (TTM)
- $0
- EBITDA
- -
- Profit Margin
- 0.00%
- ROE (TTM)
- 6069.57%
- EPS (Diluted)
- 0.00
- Book Value
- -
Recent Dividends
$0.1780CAD
Ex: Aug 17, 2026
Pay: Aug 25
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About NOVO
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| GLO | Global Atomic Corp | $0.71 | +44.90% |
| DIAM | Star Diamond Corp | $0.03 | +25.00% |
| EGLX | Enthusiast Gaming Holdings Inc | $0.04 | +14.29% |
| YRB | Yorbeau Resources Inc | $0.06 | +10.00% |
| COPR | Coppernico Metals Inc. | $0.44 | +8.64% |
| NFGC | New Found Gold Corp. | $2.42 | +7.56% |
| TELY | TelyRx Holdings Inc. | $2.25 | +7.14% |
| LABS | Medipharm Labs Corp | $0.07 | +7.14% |
NOVO.TO news timeline
2 articles covering NOVO.TO, most recent first
Latest